COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors-Reference-Cited by-同舟云学术

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors

Published:2022-04-09 Issue:6 Volume:43 Page:3519-3522
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Tanzilli Antonio^ORCID,Pace Andrea,Ciliberto Gennaro,La Malfa Antonia Marina,Buonomo Valentina,Benincasa Dario,Biscu Annamaria,Galiè Edvina,Villani Veronica

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-022-06054-3.pdf

Reference8 articles.

1. Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430–436

2. Kuderer NM, Choueiri TK, Shah DP et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395:1907–1918

3. Martín-Moro F, Marquet J, Piris M, Michael BM, Sáez AJ, Corona M, Jiménez C, Astibia B, García I, Rodríguez E, García-Hoz C, Fortún-Abete J, Herrera P, López-Jiménez J (2020) Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol 190(1):e16–e20. https://doi.org/10.1111/bjh.16801

4. Abdul-Jawad S, Baù L, Alaguthurai T et al (2021) Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients. Cancer Cell 39:257–75.e6

5. Laing AG, Lorenc A, Molino Del et al (2020) A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med 26:1623-1635.7

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review;Preventive Medicine Reports;2024-08

2. Helper Lipid-Enhanced mRNA Delivery for Treating Metabolic Dysfunction-Associated Fatty Liver Disease;Nano Letters;2024-05-24

3. Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines;Vaccines;2023-05-04

4. Literature analysis of the efficacy of COVID-19 vaccinations;2022-12-27

5. Two Cases of Rare Intratumoral Hemorrhage Following COVID-19 Vaccination;Cureus;2022-12-11